NP Life Sciences Health Industry Group Inc. (ACAT) Shareholders’ equity 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) shareholders’ equity at each fiscal year-end, per SEC filings.
$16,381FY2023 · since FY2019: $234,914 → $16,381
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $16,381 | -15.2% |
| FY2022 | $19,316 | -49.4% |
| FY2021 | $38,172 | -63.2% |
| FY2020 | $103,849 | -55.8% |
| FY2019 | $234,914 | — |
Source: SEC XBRL filings · For reference only · Not investment advice